GLPwatch

[Cloning, expressing of exendin-4 analogue and bioactivity analysis in vivo].

Sheng Wu Gong Cheng Xue Bao · 2012

Last updated 2026-05-28

Researchers created a version of the GLP-1 drug exendin-4 in bacteria, purified it to 91.8% purity, and tested it in mice. After injecting the drug, the mice’s blood sugar levels dropped significantly and their insulin levels rose compared to untreated mice (P < 0.01).

AI summary of the abstract below.

JournalSheng Wu Gong Cheng Xue Bao, 2012
Citations0
Relative citation ratio0.00
NIH percentile0
Molecules

Abstract

To construct, express and purify Exendin-4 analogue and detect its biological activity in vivo. Insert gene sequence into fusion partner ofpED plasmid which is helped to purification, entitled the new recombinant plasmid 5 Exendin-4 analogue polypeptide gene and fusion partner gene was linked by acid hydrolysisgene, transformed to E. coli BL21 and the fusion protein was induced by lactose. After acid hydrolysis, the Exendin-4 analogue polypeptide separated from fusion chaperon. Anion charge chromatography were used to further purification. 6 to 8 week-old ICR mice were injected (s.c) with Exendin-4 analogue, blood glucose and plasma insulin level was detected in different period after oral glucose tolerance test. The results show that high expression of inclusion body was induced by lactose, which accounted for 40% of germ proteins, the Exendin-4 analogue was obtained with the purity of 91.8% after being purified by anion charge chromatography. Bioactivity assay showed that the level of blood glucose of mouse which treated with exendin-4 analogue was obviously decreased to normal (P < 0.01), and the level of plasma insulin was increased obviously (P < 0.01).

Verbatim abstract via PubMed 23167199 ↗